comparemela.com

AR Asset Management Inc. purchased a new position in Marker Therapeutics, Inc. (NASDAQ:MRKR – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 40,700 shares of the company’s stock, valued at approximately $29,000. Separately, Renaissance Technologies LLC increased its stake in Marker Therapeutics […]

Related Keywords

United States , ,Renaissance Technologies ,Exchange Commission ,Ar Asset Management Inc ,Nasdaq ,Marker Therapeutics Inc ,Marker Therapeutics ,Free Report ,Get Free Report ,Visit Holdingschannel ,Marker Therapeutics Daily ,Nasdaq Mrkr ,Mrkr ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.